The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics
Abstract
BACKGROUND: Clostridium difficile infections (CDIs) are common in developed countries and affect >250,000 hospitalized patients annually in the USA. The most important risk factor for the disease is antibiotic therapy. METHODS: To determine the period at risk for CDI after cessation of antibiotics, we performed a multicentre case-control study in the Netherlands between March 2006 and May 2009. Three hundred and thirty-seven hospitalized patients with diarrhoea and a positive toxin test were compared with 337 patients without diarrhoea. Additionally, a control group of patients with diarrhoea due to a cause other than CDI (n=227) was included. RESULTS: In the month prior to the date of inclusion, CDI patients more frequently used an antibiotic compared with non-diarrhoeal patients (77% versus 49%). During antibiotic therapy and in the first month after cessation of the therapy, patients had a 7-10-fold increased risk for CDI (OR 6.7-10.4). This risk declined in the period between 1 and 3 months after the antibiotic was stopped (OR 2.7). Similar results were observed when the second control group was used. All antibiotic classes, except first-generation cephalosporins and macrolides, were associated with CDI. Second- and third-generation cephalosporins (OR 3.3 and 5.3, respectively) and carbapenems (OR 4.7) were the strongest risk factors for CDI. Patients with CDI used more antibiotic classes and more defined daily doses, compared with non-diarrhoeal patients. CONCLUSIONS: Antibiotic use increases the risk for CDI during therapy and in the period of 3 months after cessation of antibiotic therapy. The highest risk for CDI was found during and in the first month after antibiotic use. Our study will aid clinicians to identify high-risk patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Long-term impacts of antibiotic exposure on the human intestinal microbiota
Jernberg, C., Löfmark, S., Edlund, C., & Jansson, J. K. (2010) · Microbiology · doi:10.1099/mic.0.040618-0 · Cited by 1,067
Pepin, J., Saheb, N., Coulombe, M.-A., Alary, M.-E., Corriveau, M.-P., Authier, S., Leblanc, M., Rivard, G., Bettez, M., Primeau, V., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/496986 · Cited by 995
Instruments for Causal Inference: An Epidemiologist's Dream?
Hernán, M. A., & Robins, J. M. (2006) · Epidemiology · doi:10.1097/01.ede.0000222409.00878.37 · Cited by 961
Pepin, J. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050978 · Cited by 606
Antimicrobial‐Associated Risk Factors for Clostridium difficile Infection
Owens, Jr., Donskey, C. J., Gaynes, R. P., Loo, V. G., & Muto, C. A. (2008) · Clinical Infectious Diseases · doi:10.1086/521859 · Cited by 603
Wistrom, J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.1.43 · Cited by 448
Crobach, M. J. T., Dekkers, O. M., Wilcox, M. H., & Kuijper, E. J. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03098.x · Cited by 413
Self-citationBauer, M. P., Kuijper, E. J., & van Dissel, J. T. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03099.x · Cited by 366
Self-citationEastwood, K., Else, P., Charlett, A., & Wilcox, M. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01082-09 · Cited by 330
Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review
Thomas, C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg254 · Cited by 305
Dubberke, E. R., Reske, K. A., Yan, Y., Olsen, M. A., McDonald, L. C., & Fraser, V. J. (2007) · Clinical Infectious Diseases · doi:10.1086/523582 · Cited by 254
The effect of joint exposures: examining the presence of interaction
de Mutsert, R., Jager, K. J., Zoccali, C., & Dekker, F. W. (2009) · Kidney International · doi:10.1038/ki.2008.645 · Cited by 222
Bidet, P., Lalande, V., Salauze, B., Burghoffer, B., Avesani, V., Delmée, M., Rossier, A., Barbut, F., & Petit, J.-C. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.7.2484-2487.2000 · Cited by 217
Clinical Risk Factors for Severe Clostridium difficile–associated Disease
Henrich, T. J., Krakower, D., Bitton, A., & Yokoe, D. S. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1503.080312 · Cited by 215
Knol, M. J., Vandenbroucke, J. P., Scott, P., & Egger, M. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn217 · Cited by 189
Historical Perspectives on Studies of Clostridium difficile and C. difficile Infection
Bartlett, J. G. (2008) · Clinical Infectious Diseases · doi:10.1086/521865 · Cited by 188
Review of Current Literature on the Economic Burden of Clostridium difficile Infection
Dubberke, E. R., & Wertheimer, A. I. (2009) · Infection Control & Hospital Epidemiology · doi:10.1086/592981 · Cited by 184
Bajaj, J. S., Ananthakrishnan, A. N., Hafeezullah, M., Zadvornova, Y., Dye, A., McGinley, E. L., Saeian, K., Heuman, D., Sanyal, A. J., & Hoffmann, R. G. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.615 · Cited by 175
Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection
Dial, S., Kezouh, A., Dascal, A., Barkun, A., & Suissa, S. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071812 · Cited by 166
Carignan, A., Allard, C., Pépin, J., Cossette, B., Nault, V., & Valiquette, L. (2008) · Clinical Infectious Diseases · doi:10.1086/588291 · Cited by 161
Attributable Outcomes of EndemicClostridium difficile–associated Disease in Nonsurgical Patients
Dubberke, E. R., Butler, A. M., Reske, K. A., Agniel, D. M., Olsen, M. A. A., D’Angelo, G., McDonald, L. C., & Fraser, V. J. (2008) · Emerging infectious diseases · doi:10.3201/eid1407.070867 · Cited by 156
The Microecology of Clostridium difficile
Wilson, K. H. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/16.supplement_4.s214 · Cited by 140
Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands, 2005
Paltansing, S., van den Berg, R. J., Guseinova, R. A., Visser, C. E., van der Vorm, E. R., & Kuijper, E. J. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01793.x · Cited by 115
Self-citationQuinolone Use as a Risk Factor for Nosocomial Clostridium difficile-Associated Diarrhea
Yip, C., Loeb, M. B., Salama, S. E., Moss, L., & Olde, J. (2001) · Infection Control and Hospital Epidemiology · doi:10.1086/501954 · Cited by 105
Debast, S. B., Vaessen, N., Choudry, A., Wiegers-Ligtvoet, E. A. J., van den Berg, R. J., & Kuijper, E. J. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02713.x · Cited by 71
Self-citationPrevalence of Diarrhea at a University Hospital and Association with Modifiable Risk Factors
Garey, K. W., Graham, G., Gerard, L., Dao, T., Jiang, Z. D., Price, M., & DuPont, H. L. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h028 · Cited by 49
Ecological impact of the des-F(6)-quinolone, BMS-284756, on the normal intestinal microflora
Nord, C. E., Gajjar, D. A., & Grasela, D. M. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00414.x · Cited by 16
Antibiotic Stewardship and Clostridium difficile–Associated Disease
Nuila, F., Cadle, R. M., Logan, N. D., & Musher, D. M. (2008) · Infection Control and Hospital Epidemiology · doi:10.1086/591450 · Cited by 14
Cited by
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690
Macy, E., & Contreras, R. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.021 · Cited by 829
Association of adverse events with antibiotic use in hospitalized patients.
Tamma, P. D., Avdic, E., Li, D. X., Dzintars, K., & Cosgrove, S. E. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.1938 · Cited by 800
Clostridium difficile infection: review
Czepiel, J., Dróżdż, M., Pituch, H., Kuijper, E. J., Perucki, W., Mielimonka, A., Goldman, S., Wultańska, D., Garlicki, A., & Biesiada, G. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03539-6 · Cited by 702
Self-citationvan Prehn, J., Reigadas, E., Vogelzang, E. H., Bouza, E., Hristea, A., Guery, B., Krutova, M., Norén, T., Allerberger, F., Coia, J. E., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.09.038 · Cited by 640
Self-citation
Metadata
- Authors
- Hensgens, M. P. M., Goorhuis, A., Dekkers, O. M., & Kuijper, E. J.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-12-06
- Volume
- 67
- Issue
- 3
- Pages
- 742-748
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2165811639
- Cited by
- 399
- References
- 29
- FWCI
- 12.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.